Renaissance Technologies’s Iterum Therapeutics ITRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $470K | Buy |
471,900
+231,000
| +96% | +$230K | ﹤0.01% | 2865 |
|
|
2025
Q1 | $296K | Sell |
240,900
-197,916
| -45% | -$243K | ﹤0.01% | 2929 |
|
|
2024
Q4 | $777K | Buy |
+438,816
| New | +$777K | ﹤0.01% | 2623 |
|
|
2024
Q3 | – | Sell |
-64,022
| Closed | -$73.3K | – | 3705 |
|
|
2024
Q2 | $73.3K | Sell |
64,022
-46,304
| -42% | -$53K | ﹤0.01% | 3237 |
|
|
2024
Q1 | $170K | Buy |
110,326
+60,404
| +121% | +$93.1K | ﹤0.01% | 3267 |
|
|
2023
Q4 | $98K | Buy |
49,922
+3,000
| +6% | +$5.89K | ﹤0.01% | 3305 |
|
|
2023
Q3 | $38K | Buy |
46,922
+4,138
| +10% | +$3.35K | ﹤0.01% | 3440 |
|
|
2023
Q2 | $46K | Buy |
42,784
+3,900
| +10% | +$4.19K | ﹤0.01% | 3632 |
|
|
2023
Q1 | $39K | Buy |
38,884
+1,800
| +5% | +$1.81K | ﹤0.01% | 3710 |
|
|
2022
Q4 | $31K | Buy |
37,084
+2,400
| +7% | +$2.01K | ﹤0.01% | 3883 |
|
|
2022
Q3 | $56K | Buy |
34,684
+13,131
| +61% | +$21.2K | ﹤0.01% | 3724 |
|
|
2022
Q2 | $65K | Buy |
21,553
+14,346
| +199% | +$43.3K | ﹤0.01% | 3949 |
|
|
2022
Q1 | $38K | Sell |
7,207
-1,273
| -15% | -$6.71K | ﹤0.01% | 3943 |
|
|
2021
Q4 | $50K | Sell |
8,480
-34,491
| -80% | -$203K | ﹤0.01% | 3783 |
|
|
2021
Q3 | $360K | Sell |
42,971
-176,316
| -80% | -$1.48M | ﹤0.01% | 3017 |
|
|
2021
Q2 | $7.6M | Buy |
+219,287
| New | +$7.6M | 0.01% | 1368 |
|
|
2021
Q1 | – | Sell |
-48,860
| Closed | -$725K | – | 3504 |
|
|
2020
Q4 | $725K | Buy |
+48,860
| New | +$725K | ﹤0.01% | 2658 |
|